The emerging role of the IL-17B/IL-17RB pathway in cancer - Inserm - Institut national de la santé et de la recherche médicale Accéder directement au contenu
Article Dans Une Revue Frontiers in Immunology Année : 2020

The emerging role of the IL-17B/IL-17RB pathway in cancer

Jeremy Bastid
  • Fonction : Auteur
Cecile Dejou
  • Fonction : Auteur
Aurelie Docquier
  • Fonction : Auteur

Résumé

Among inflammatory mediators, a growing body of evidence emphasizes the contribution of the interleukin 17 (IL-17) cytokine family in malignant diseases. Besides IL-17A, the prototypic member of the IL-17 family, several experimental findings strongly support the role of the IL-17B/IL-17 receptor B (IL-17RB) pathway in tumorigenesis and resistance to anticancer therapies. In mouse models, IL-17B signaling through IL-17RB directly promotes cancer cell survival, proliferation, and migration, and induces resistance to conventional chemotherapeutic agents. Importantly, recent work by our and other laboratories showed that IL-17B signaling dramatically alters the tumor microenvironment by promoting chemokine and cytokine secretion which foster tumor progression. Moreover, the finding that elevated IL-17B is associated with poor prognosis in patients with pancreatic, gastric, lung and breast cancer strengthens the results obtained in pre-clinical studies and highlights its clinical relevance. Here, we review the current understanding on the IL-17B/IL-17RB expression patterns and biological activities in cancer and highlight issues that remain to be addressed to better characterize IL-17B and its receptor as potential targets for enhancing the effectiveness of the existing cancer therapies.
Fichier principal
Vignette du fichier
Revised Bastid et al final HAL.pdf (300.77 Ko) Télécharger le fichier
Origine : Fichiers produits par l'(les) auteur(s)
Loading...

Dates et versions

inserm-02546091 , version 1 (17-04-2020)

Identifiants

Citer

Jeremy Bastid, Cecile Dejou, Aurelie Docquier, Nathalie Bonnefoy. The emerging role of the IL-17B/IL-17RB pathway in cancer. Frontiers in Immunology, In press, Epub ahead of print. ⟨10.3389/fimmu.2020.00718⟩. ⟨inserm-02546091⟩
65 Consultations
76 Téléchargements

Altmetric

Partager

Gmail Facebook X LinkedIn More